An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Clinical trial NCT06435312 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06435312
- Sponsor
- UCB Biopharma SRL
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-19
- Primary completion
- 2027-10-26
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.